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Abstract
Juliana A. D’Onofrio
EXAMINING THE FEASIBILITY OF IMPLEMENTING A MINDFULNESS-BASED
CANCER RECOVERY BIBLIOTHERAPY FOR THE TREATMENT OF
PSYCHOSOCIAL DISTRESS IN WOMEN WITH BREAST CANCER
2021-2022
Jim A. Haugh, Ph.D.
Doctor of Philosophy

Breast cancer is the most common cancer diagnosis and the second leading cause
of cancer-related deaths for women in the United States. Clinical depression and anxiety
occur frequently within this population. Subclinical symptoms are also common and
include increased sense of vulnerability, agitation, and grief as well as fears related to
pain, creating a burden for one’s family, and death. Due to the variety of negative
implications women experience from psychosocial distress, improving quality of life and
reducing symptomatology becomes imperative. A plethora of research supports the use of
Mindfulness-Based Cancer Recovery (MBCR). Considering the challenges present
within traditional psycho-oncological care (e.g., interdisciplinary integration, financial
funding, burden of time intensive oncological and psychological treatment, appropriate
staffing, etc.), the current study examines the feasibility of implementing an empirically
supported psychotherapeutic approach (i.e., MBCR) through an alternative modality of
treatment (i.e., guided bibliotherapy). Participants included women with breast cancer
who were recruited from an ambulatory oncology clinic. Results shed light on a variety
of factors involved in determining feasibility. Implications of acceptability, recruitment
capability, demand and data collection, design procedures and implementation,
integration, and effectiveness are discussed.
Keywords: feasibility study, psycho-oncology, breast cancer, bibliotherapy
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Chapter 1
Introduction
With a lifetime prevalence of 13%, breast cancer is the most common cancer
diagnosis and the second leading cause of cancer-related death for women in the United
States (American Cancer Society, 2020). To an extent, experiencing psychosocial distress
within the context of a cancer diagnosis and treatment is expected. However, clinically
significant depression and anxiety occur frequently, with rates ranging from 1-50% and
30-40%, respectively. Subclinical symptoms are also common and include increased
sense of vulnerability, agitation, and grief as well as fears related to pain, creating a
burden for one’s family, and death. Previous research suggests rates of depression are
highest in younger women, within the first year following diagnosis, while undergoing
adjunctive treatment including radiation, chemotherapy, or surgery, and with recurrence
(Burgess et al., 2005; Fann et al., 2008; Hegel et al., 2002; Pasquini & Biondi, 2006;
Miller, Bowen, Croyle, & Rowland, 2009).
Patients who experience significant distress or difficulties with the adjustment to
cancer are less likely to adhere to medical treatments, attend cancer screenings, or
maintain healthy living (Andersen, Kiecolt-Glaser, & Glaser, 1994; Andersen, GoldenKreutz, Emery, & Thiel, 2009; Pinquart & Duberstein, 2010). Implications warrant
research on psychological treatments, their efficacy, and ways to increase dissemination
within this population. Since the formal beginnings of psycho-oncology in the mid1970s, literature within this area continues to support integrative, collaborative, and
patient-centered approaches to address distress (Holland, 2002; Watson & Dunn, 2016).
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For example, the psycho-oncology consultation model of care (POCM) offers guidelines
and recommendations for implementing brief interventions for inpatients receiving
chemotherapy and radiation (Deshields & Nanna, 2010). In addition, ambulatory
oncology clinics provide an opportunity for patients to receive more traditional
interventions, including individual psychotherapy, support groups, and/or medication
management.
A variety of psychotherapeutic treatments and related constructs have been shown
to effectively reduce distress across the cancer care continuum. One such construct that
has gained substantial attention over the past two decades is mindfulness. Mindfulness
has been defined as purposefully and non-judgmentally attending to the present moment
as to alter a negative response to distressing stimuli (Kabat-Zinn, 1982). Mindfulness can
also be defined and understood as consisting of five independent, yet interrelated facets.
These facets consist of the ability to observe and describe internal or external stimuli, act
with awareness, accept without judgement, and reduce harmful reactivity to stressful
experiences (Baer, Smith, Hopkins, Krietemeyer, & Toney, 2006).
Mindfulness-Based Stress Reduction (MBSR) was first coined by Jon Kabat-Zinn
in 1990. He developed MBSR to reduce refractory and chronic pain as well as anxiety.
Formal mindfulness practices within MBSR include body scan, mindful yoga, sitting
meditation, walking meditation, and loving-kindness meditation. There exists a wide
array of benefits that result from increasing our level of trait mindfulness through
frequent practice and attendance to our state level of mindfulness. More specifically,
mindfulness contributes to psychological wellbeing as it circumvents the negative
implications of acute and chronic stress. Evidence continues to support mindfulness as a
2

transtherapeutic tool to target core cognitive, emotional, behavioral, and physiological
processes that are present across several mental health conditions (Greeson, Garland, &
Black, 2014; Shapiro & Carlson, 2017). As such, MBSR has been adapted and made
applicable to numerous diagnostic populations for specific psychotherapeutic purposes.
Within mindfulness-based psychotherapies, the core therapeutic components are
consistent with MBSR. Protocols are overtly geared towards the promotion and teaching
of mindfulness-based practice (Shapiro & Carlson, 2017). For example, Segal, Williams,
and Teasdale (2002) developed Mindfulness-Based Cognitive Therapy (MBCT) for those
experiencing depression. In addition to MBSR, they addressed feelings of hopelessness,
unworthiness, and persistent rumination present in depressive disorders. Those being
treated with MBCT are taught to change their relationship with negative thought patterns
in an effort to prevent or buffer against future depressive relapse (Segal, Williams, &
Teasdale, 2002). In the mid-1990s, Linda E. Carlson, Ph.D., and her colleagues decided
to adapt components from MBCT to create an in-person, group therapy program unique
to individuals coping with cancer treatment and survivorship. Mindfulness-Based Cancer
Recovery (MBCR) incorporates the core MBSR components of formal and informal
mindfulness meditation as well as the focus on altering one’s relationship with feelings of
hopelessness.
Since the development of MBCR, strong empirical support has established its
efficacy and effectiveness for individuals diagnosed with cancer, and more specifically,
women coping with breast cancer. Carlson et al. (2013) first examined cortisol levels,
perceived mood, stress, quality of life, and social support in a sample of 271 breast cancer
survivors. Participants were randomized to group MBCR or Supportive-Expressive
3

Group Therapy (SET). Following 18 hours of professional contact within group
protocols, results indicated MBCR to significantly improve stress, quality of life, and
social support for distressed participants when compared to those in SET. Additional
results from studies have indicated sustained improvements in chemotherapy or radiation
side effects, stress symptoms, sleep quality, fatigue, anxiety, and depression (Blaes et al.,
2016; Carlson, 2013; Carlson, 2016; Carlson et al., 2015; Carlson et al., 2019; Toivonen
et al., 2020). One study also suggested MBCR to be an effective alternative to CognitiveBehavioral Therapy for Insomnia (CBT-I; Schellekens et al., 2017).
Despite empirically supported treatments and opportunities to provide supportive
psycho-oncological care, some of the longstanding attitudinal and logistical challenges
continue to exist. Namely, the POCM and referral to ambulatory services largely relies on
consistent and effective collaboration with medical providers (Deshields & Nanna, 2010).
Unfortunately, previous research has shown nonreferral is commonly the result of the
patient’s reluctance to discuss psychosocial distress. Moreover, it has been posited that
communication becomes further complicated by a mutual misconception between
provider and patient, as they may both believe the other will initiate discussions regarding
psychological symptoms (Kam, Knott, Wilson, & Chambers, 2012; Senf, Fettel,
Demmerle, & Maiwurm, 2018). While the integration of behavioral consultation into
medical care has been supported to promote interdisciplinary collaboration and improve
patient follow-up on referral (IOM, 2008; Pincus, 2003), financial funding, staffing, and
patient volume remain logistical challenges (Deshields & Nanna, 2010).
One alternative collaborative care model that aims to match the optimal
intervention to the patient is the stepped-care model (SCM; Davison, 2000; van Straten et
4

al., 2015). Within a stepped-care approach, clinicians structure treatment in “steps.” As
such, treatment begins with the least intensive or invasive intervention for presenting
concerns. O’Donohue and Draper (2011) outline SCMs specific for various diagnostic
populations. The SCMs specific to depression (Broten, Naugle, Kalata, & Gaynor, 2011)
and anxiety (Hazlett-Stevens, 2011) follow the same structure. These models typically
define Step 1 as watchful waiting, or inactive monitoring of symptoms. If symptoms do
not remit during the watchful waiting phase, patients might move to Step 2, which
includes psychoeducation or self-administered treatments (e.g., bibliotherapy, mobile
applications, and/or computer-based interventions). Step 3 consists of traditional forms of
treatment, which are individual psychotherapy, pharmacotherapy, or a combined
approach. Finally, as the highest level, Step 4 consists of intensive outpatient programs,
partial day hospitalization, and inpatient programs (Broten, Naugle, Kalata, & Gaynor,
2011; Hazlett-Stevens, 2011).
Studies have been inconsistent with regards to examining the effectiveness of
SCMs. Some meta-analyses have determined SCMs to be comparable to standard care
(Firth, Barkham, & Kellett 2015; van Straten et al., 2015). However, other studies have
found SCMs to be significantly more effective than standard care (Araya et al., 2003; Ell
et al., 2008). Firth, Barkham, and Kellett (2015) partially attribute these differences to the
heterogeneity of how controlled trials have organized the SCM approach. Within the
SCM, treatment prescription typically starts with the least intensive option (i.e., watchful
waiting). However, authors recommend considering the role of the patient when making
“stepping decisions” (Firth, Barkham, & Kellet, 2015). Much like evidence-based
behavioral practice in psychology (EBBP), the role of the patient within SCMs refers to
5

clinicians attending to treatment preferences, presenting symptomatology, and patient
characteristics (American Psychological Association [APA] Task Force, 2016). For
example, an individual presenting to an emergency department with severe depressive
symptoms, suicidal ideation, and preference for inpatient services would not be
appropriate for a watchful waiting approach or even outpatient follow-up. It has been
empirically established that matching an individual with their preferred treatment has
been found to improve clinical outcomes, the therapeutic alliance, adherence, motivation,
and satisfaction (Iacoviello et al., 2007, Kwan, Dimidjian, & Rizvi, 2010; Lin et al.,
2005; Lindhiem, Bennett, Trentacosta, & McLear, 2014; Norcross & Lambert, 2018;
Norcross & Wampold, 2011; Swift, Callahan, & Vollmer, 2011; Swift & Greenberg,
2015). In fact, Carlson et al. (2014), found that women with breast cancer who were
randomized to their preferred treatment, regardless of modality (MBCR versus SET),
comparatively improved on measures of quality of life and spiritual well-being.
D’Onofrio, Haugh, and Herbert (2018) previously examined treatment
preferences for depression in a sample of women diagnosed with breast cancer. The
overarching aim was to explore a possible method for deciding which step to begin
treatment with when utilizing a SCM approach. The authors systematically assessed
symptom severity, treatment preferences, and perceived acceptability of the SCM. In
addition, the authors explored additional patient characteristics to examine how these
variables were associated with final treatment preference. Patient characteristics included
resilience and illness perceptions, which have been associated with symptom severity and
psychosocial functioning following a cancer diagnosis (Min et al., 2012; Sharpley,
Bitiska, Wootten, & Christie, 2014).
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Participants were presented with a description of the SCM as well as descriptions
of the treatments included within each step. They were asked to indicate the step and
corresponding treatment they would prefer if seeking help for depressive symptoms.
Regarding characteristics and symptoms, results indicated less resilience and more
harmful cognitive and emotional perceptions of illness were associated with increased
levels of self-reported depression. Results also indicated that those who reported higher
symptoms tended to prefer more intensive levels of treatment (e.g., Step 3 or Step 4).
While this trend was observed, patients most frequently indicated a strong preference to
begin treatment with Step 2 through a self-help approach. Patients also most frequently
preferred guided compared to unguided self-help as well as the use of books as opposed
to mobile applications or internet-based programs (D’Onofrio, Haugh, & Herbert, 2018).
Given these indicated preferences, the current study considered guided bibliotherapy as a
psychological treatment.
Guided bibliotherapy comes with a variety of advantages when compared with
traditional forms of psychotherapy. For example, bibliotherapy is largely cost-effective
(GoodTherapy, 2016), which acts to circumvent the barrier of financial funding – a major
challenge to psychosocial care within oncology. In addition, a diagnosis of cancer likely
presents the additional burden of time-intensive oncological treatments and/or frequent
medical appointments. Bibliotherapy is self-administered and able to be completed at
one’s own leisure, which might be one way to reduce the burden of time involved in
traditional psychotherapy. Finally, guided bibliotherapy has been demonstrated to be an
effective, stand-alone treatment for minimal to moderate mental health symptoms (Bilich
et al., 2008; Floyd, 2003; Gregory, Schwer-Canning, Lee, & Wise, 2004). Taken
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together, meta-analyses have supported the use of bibliotherapy as an appropriate
treatment within SCMs (O’Donohue & Draper, 2011; van Straten, Hill, Richards, &
Cuijpers, 2015).
Due to the many advantages, bibliotherapy has been examined to treat common
mental health concerns within oncology. Malibiran, Tariman, and Amer (2018) appraised
existing evidence and found bibliotherapy to be “…acceptable and beneficial in
alleviating patient-reported anxiety and depression and improving coping skills in
patients diagnosed with cancer.” In this review, the authors posited the predominant
limitation is the lack of randomized control trials to establish causality. However,
preliminary evidence does exist for mindfulness-based bibliotherapy, which has shown
improvements in mindfulness, wellbeing, and quality of life as well as reductions in
depression, anxiety, and stress (Hazlett-Stevens & Oren, 2017; Stahl & Goldstein, 2010;
Taylor, Strauss, & Cavanagh, 2021). Taylor, Strauss, & Cavanaugh (2021) also found
significantly greater effects on outcomes when non-digital mindfulness-based self-help
interventions were used.
As mentioned previously, the efficacy of MBCR when implemented through a
group therapy format has been established (Carlson, 2016; Carlson et al., 2015; Carlson
et al., 2019, etc.). To further disseminate, the creators have also explored whether
delivering MBCR through alternative formats results in similar efficacy. For example,
MBCR was examined as an online eTherapy program. Results of feasibility and trial
studies indicate significant promise in reaching and treating psychosocial distress in
underserved populations (i.e., eCALM Trial; Zernicke et al., 2013, Zernicke et al., 2014;
Zernicke et al., 2016). In addition, Linda E. Carlson, Ph.D. and Michael Speca, PsyD.,
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wrote Mindfulness-Based Cancer Recovery: A Step-by-Step MBSR Approach to Help You
Cope with Treatment & Reclaim Your Life (Carlson & Speca, 2011) for individuals to
utilize as a home-based self-help.
However, Mindfulness-Based Cancer Recovery: A Step-by-Step MBSR Approach
to Help You Cope with Treatment & Reclaim Your Life (Carlson & Speca, 2011) has yet
to be empirically examined as a bibliotherapy. As a result, the overarching goal was to
fill this gap in MBCR literature as well as attend to the previously found preferences for
guided versus unguided self-help as well as the use of books (bibliotherapy) versus
mobile applications or internet-based programs. To inform future research and possible
randomized-control trial, the current study sought to examine the feasibility of
implementing a MBCR guided bibliotherapy to reduce distress in a sample of women
diagnosed with breast cancer. Patients were recruited from an ambulatory oncology clinic
during a one-year period. Feasibility was primarily defined through estimated target rates
of patient interest, eligibility, consent, and participant completion of an eight-week
guided bibliotherapy protocol. Additional areas of focus for feasibility included
exploration into the acceptability of the intervention, recruitment capability, demand and
data collection, design procedures and implementation, integration within the clinic, and
effectiveness of the intervention protocol. Our secondary goal was to continue exploring
the potential impact treatment preferences might have on adherence and outcome.
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Chapter 2
Method
Study Design
The overarching goal of the study was to examine the feasibility of implementing
a protocol for an eight-week guided bibliotherapy in an oncology clinic for women with
breast cancer. First, the study included a cross-sectional survey, which is referred to
henceforth as the baseline survey. If patients completed the baseline survey and met
additional eligibility criteria, they were presented with the option to participate in the
guided bibliotherapy. Inclusion and exclusion criterion varied slightly for the baseline
survey and the bibliotherapy. As such, informed consent was obtained for each
component. The bibliotherapy involved a longitudinal and repeated measures design.
Patients had the option to only participate in the baseline survey. However, for the
bibliotherapy protocol, participants were asked to complete surveys at five additional
time points. Time points included every two weeks across the eight-week protocol as well
as a one-month follow-up survey to explore any maintained effects.
Inclusion and Exclusion Criteria
While it is possible for men to experience a diagnosis of breast cancer, the
incidence rates are approximately 1.28% and mortality rates are 0.26% (Center for
Disease Control and Prevention, 2020). As a result, the current study focused on and
included only women diagnosed with breast cancer. With regards to the baseline survey,
patients who were a) English-speaking, b) 18 years old or older, and c) diagnosed with
breast cancer were eligible to participate. Patients with a primary cancer diagnosis other
10

than breast were excluded. With regards to the bibliotherapy, patients who were a)
English-speaking, b) 18 years old or older, c) diagnosed with breast cancer, and d)
experiencing mild to moderate levels of both depression and anxiety, as indicated by
scores of 5-14 on the PHQ-9 and GAD-7, were eligible to participate. Patients who a) had
a primary cancer diagnoses other than breast, b) were experiencing minimal or severe
levels of depression or anxiety, as indicated by respective scores of 0-4 or 15+ on the
PHQ-9 or GAD-7, and/or b) endorsing suicidal ideation, as indicated by a score of 1 or
higher on item 9 of the PHQ-9 were excluded. Those who indicated any suicidal ideation
were referred to the protocol within the clinic, which included additional risk assessment
with the Columbia Suicide Severity Rating Scale (CSSR-S; Posner, et al., 2010).
Guided Bibliotherapy
Given the established empirical support for MBCR, the current study utilized
Mindfulness-Based Cancer Recovery: A Step-by-Step MBSR Approach to Help You Cope
with Treatment & Reclaim Your Life (Carlson & Speca, 2011). The self-help book was
written based on the in person, eight-week group therapy program facilitated by the
authors. Given the length of their program, an eight-week guided bibliotherapy was
created. Eight weekly modules were developed to guide participants through reading and
engaging in mindfulness-based practices discussed within the text (See Appendix A).
Feasibility
There has been a rising call for evidence-based practice (EBP). However, most
EBP recommendations and/or guidelines have been developed following randomizedcontrol trials (RCTs). While RCTs provide the ability to make causal inferences,
increasing internal validity can decrease measures of external validity, such as
11

generalizability and dissemination (Green & Glasgow, 2006). As a result, psychological
researchers are progressively placing emphasis on feasibility research within the initial
phase of intervention development. According to Gadke, Kratochwill, and Gettinger
(2021), the overarching benefit of feasibility research is the potential to optimize “realworld” implementation of EBP. Bowen et al. (2009) initially defined eight areas of focus
commonly explored in feasibility studies as well as corresponding research questions and
potential outcome measures. These eight areas included acceptability, demand,
implementation, practicality, adaptation, integration, expansion, and limited efficacy.
Gadke, Kratochwill, and Gettinger (2021) recently expanded upon these areas to include
dimensions pertaining to recruitment, data collection, design procedures, and social
validity. The current study focused on a number of these areas as well as the
corresponding research questions and outcomes proposed by mentioned authors. Please
see Table 1 for full descriptions of areas and corresponding research questions utilized in
the current study.
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Table 1
Key Areas of Focus, Research Questions, and Outcomes
Area of Focus
Research Questions
Acceptability

•

•

Recruitment
Capability

•

•

Demand and
•
Data Collection
•
Design
•
Procedures and
Implementation
•
Integration

•

To what extent is the SCM
suitable or attractive to
program deliverers and/or
recipients?
To what extent is the MBCR
bibliotherapy suitable or
attractive to program
deliverers and/or recipients?
Can participants who will be
eligible for and benefit from
the baseline survey be
identified?
Can participants who will be
eligible for and benefit from
the MBCR bibliotherapy be
identified?
To what extent are
components of the SCM
likely to be used (i.e.,
bibliotherapy)?
Are data collection
procedures appropriate?

•

To what extent can the
MBCR bibliotherapy be
successfully delivered to
intended participants?
Is the research design
appropriate?
To what extent can
bibliotherapy be integrated
within the oncology clinic?

•

•
•
•
•
•

•
•
•

•
•
•
•
•

Satisfaction and acceptability
ratings
Perceived appropriateness
and fit within the
organizational culture
Perceived effects on
organization
Patients identified for
participation
Patients eligible for
participation
Patients appropriate to
approach for participation

Expressed interest or
intention to use (e.g., consent
for participation)
Actual use (e.g., adherence)
Burden of repeated measures
design
Potential impact of
modifications
Qualitative data
Expectations of participants

Overall feasibility
Perceived fit within the
organization
Sustainability and costs to
organization
Individual data (n=3)
Change in measures over
time

Is there preliminary evidence •
of potential for the MBCR
•
bibliotherapy to bring about
positive change?
Note. Based on definitions found in Bowen et al. (2009) and Gadke, Kratochwill, and
Gettinger (2021) on feasibility research.
Effectiveness

•

Outcomes
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According to Freedland (2016), feasibility studies should support the researcher’s
ability to conduct a successful randomized control trial (RCT) within the desired setting
and with the desired procedure, patients, intervention, and measures. First, census data
within the oncology clinic was obtained. The numbers documented of patients with
newly diagnosed breast cancer were available during the previous two years. The clinic
saw 142 new breast cancer cases in 2019 and 98 new breast cancer cases in 2020.
Research coordinators of the clinic attributed the decrease in cases to the ongoing
COVID-19 pandemic.
For the current study, benchmarks for feasibility were based on existing research
within this topic area. Specifically, we deferred to the target eligibility, consent, and
completion rates outlined in Zernicke et al. (2014). The authors examined the feasibility
of an online MBCR eTherapy program for individuals who completed primary cancer
treatment. To support feasibility, 30% eligibility rates of total patients screened for the
baseline survey as well as the bibliotherapy were expected. Appropriateness to approach
within the eligibility rate (i.e., total approached) was included. In addition, an 85%
consent rate from eligible patients was expected. Finally, of those who consented to
participate in the bibliotherapy, an 85% completion rate for each time point (Zernicke et
al., 2014) was expected. Figure 1 illustrates the design and how participants were tracked
throughout the duration of the study.
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Figure 1
Study Design Flow Diagram
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Participants
A total of 40 women completed the baseline survey. Ages ranged from 33 to 84,
with a mean of 63.68 (SD=12.78) and mode of 71 years old. Thirty-two (80%)
participants identified as White/Caucasian, followed by Black/African American (n=4;
10%), American Indian/Alaska Native (n=2; 5%), and Pacific Islander American (n=1;
2.5%); one participant preferred not to indicate race. Thirty-six (90%) participants
identified as Non-Hispanic/Latinx, while three participants (7.5%) preferred not to
indicate ethnicity. Five patients partially completed the survey. Specifically, participation
was discontinued due to either patient fatigue, acute distress, difficulty using the provided
iPad, and/or time constraint.
Of the 40 participants who completed the baseline survey, 10 patients consented
to participate in the MBCR bibliotherapy. Ages ranged from 45 to 84, with a mean of
66.8 (SD=12.52) and mode of 84 years old (n=2). All participants (N=10; 100%)
identified as White/Caucasian and Non-Hispanic/Latinx. Participants indicated a variety
of oncological diagnoses, such as triple negative breast cancer, bilateral breast cancer
(stage II and stage III) with lymph node involvement, hormone positive (HER-2) breast
cancer, hormone receptor-positive (ER/PR+) breast cancer, and invasive ductal
carcinoma. Three participants (30%) indicated to be in active treatment, while seven
participants (70%) indicated to be in maintenance. Participants indicated experience with
chemotherapy (n=6, 60%) radiation (n=4; 40%), and hormone therapy (n=2, 20%). Half
of participants (n=5) indicated having previously undergone surgery. Seven participants
(70%) indicated prior experience with symptoms of depression and anxiety. Of these
seven participants, four participants (57.1%) indicated their experience only occurred
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following their cancer diagnosis. Three participants (42.9%) indicated prior experience
with psychiatric treatment, with equal dispersion across psychotherapy (talking treatment;
n=1), medication (drug treatment; n=1), and a combined approach (psychotherapy and
medication; n=1). Of those who indicated experience with symptoms without history of
psychiatric treatment (n=4; 57.1%), two participants indicated reasons to include time
constraint (“Too many other appointments”) and perceived need (“Thought I was
managing at the time”), while two participants preferred not to answer.
Measures
Patient Health Questionnaire, 9-Item (PHQ-9)
The PHQ-9 (Spitzer, Kroenke, & Williams, 1999) is a 9-item self-report
questionnaire that assesses each of the Diagnostic and Statistical Manual for Mental
Disorders (DSM) criteria for Major Depressive Disorder (MDD). Items are rated on a 4point Likert scale, ranging from not at all (0) to nearly every day (3). Items are summed
to obtain total scores that range from 0 to 27. A total score of 0 to 4 indicates a minimal
level of depression, 5 to 9 indicates a mild level of depression, 10 to 14 indicates a
moderate level of depression, 15 to 19 indicates a moderately severe level of depression,
and 20-27 indicates a severe level of depression. A total score of 10 or greater is used as a
clinical cut-off for the indication for a probable DSM-5 diagnosis of MDD. The PHQ-9
has high sensitivity (88%) and specificity (88%) as well as high reliability, with a
Cronbach’s alpha of 0.89 and test-retest of 0.84 (Kroenke, Spitzer, & Williams, 2001).
The PHQ-9 demonstrated adequate internal consistency in the current sample a=90.
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Generalized Anxiety Disorder Scale, 7-Item (GAD-7)
The GAD-7 (Spitzer, Kroenke, Williams, & Löwe, 2006) is a 7-item self-report
questionnaire that assesses each of the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV) criteria for Generalized Anxiety Disorder (GAD).
Items are rated on a 4-point Likert scale, ranging from not at all (0) to nearly every day
(3). Items are summed to obtain total scores that range from 0 to 21. A total score
between 0 to 4 indicates a minimal level of anxiety, 5 to 9 indicates a mild level of
anxiety, 10-14 indicates a moderate level of anxiety, and 15 to 21 indicates a severe level
of anxiety. A total score of 10 or greater is used as a clinical cut-off for the indication for
a probable DSM-IV diagnosis of GAD. The GAD-7 has high sensitivity (89%) and
specificity (82%) as well as high reliability, with a Cronbach’s alpha of 0.92 and testretest of 0.83 (Spitzer, Kroenke, Williams, & Löwe, 2006). The GAD-7 demonstrated
adequate internal consistency in the current sample a=0.94.
The Connor-Davidson Resilience Scale, 10-Item (CD-RISC 10)
The CD-RISC 10 (Connor, & Davidson, 2003) is a 10-item self-report
questionnaire that quantifies an individual’s level of resilience. Items are rated on a 5point Likert scale, ranging from not true at all (0) to true nearly all of the time (4). To
calculate the total score, items are summed and range from 0 to 40, with higher total
scores reflecting greater levels of resilience. Total scores are typically compared to the
means of the specific population being studied. One study indicated that the mean total
score for the CD-RISC 10 in a sample of breast cancer patients was 27.6 (SD=5.9;
Markovitz et al. 2014). The CD-RISC 10 has demonstrated good test-retest reliability (r =
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0.88; Notario-Pacheco et al., 2014). The CD-RISC demonstrated high internal
consistency in the current sample a=0.95.
Brief Illness Perception Questionnaire (IPQ-B)
The Brief IPQ (Broadbent, Petrie, Main, & Weinman, 2006) is a 9-item selfreport questionnaire that assesses an individual’s cognitive and emotional perceptions of
their illness. The Brief IPQ includes eight items that are asked on a 10-point Likert scale
and each item’s Likert-scale is specific to the question being asked. The following is an
example of a question and its corresponding Likert-scale: “How much does your illness
affect your life?” with a 10-point Likert scale ranging from no affect at all (1), to severely
affects my life (10). The ninth item on the Brief IPQ provides qualitative data. The ninth
item is an open-ended question, which asks the individual to rank-order the three most
important factors that they believe caused their illness. For the purpose of the current
study, this item was excluded as a means to lessen psychological risk to the participant.
To calculate the total score, items are summed and range from 10-80, with higher total
scores indicating a more threatening view of the illness. The Brief IPQ has demonstrated
good test-retest reliability at three and six weeks (r=.48 .70 and r=.42-.75, respectively;
Broadbent, Petrie, Main, & Weinman, 2006). The Brief IPQ demonstrated adequate
internal consistency in the current sample a=0.74.
Five Facet Mindfulness Questionnaire, Short Form (FFMQ-SF)
The FFMQ-SF (Bohlmeijer, ten Klooster, Fledderus, Veehof, & Baer, 2011) is a
24-item self-report questionnaire that assesses an individual’s endorsement on the five
facets of mindfulness. The facets of mindfulness include the following: a) observing (4
items; e.g., ‘I pay attention to physical experiences, such as the wind in my hair or sun on
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my face’), b) describing (5 items, e.g., ‘I’m good at finding the words to describe my
feelings’), c) acting with awareness (5 items, e.g., ‘I find it difficult to stay focused on
what’s happening in the present moment’), d) nonjudging of inner experience (5 items;
e.g., ‘I tell myself that I shouldn’t be feeling the way I’m feeling’), and (e) nonreactivity
to inner experience (5 items; e.g., ‘I watch my feelings without getting carried away by
them’). Items are rated on a 5-point Likert scale, ranging from never or very rarely true
(1) to very often or always true (5). Items that correspond to each specific facet are
summed to obtain total subscale scores, while all items are summed to obtain a total
overall score. Higher scores indicate greater endorsements of mindfulness. The FFMQSF subscales have demonstrated adequate to high reliability, with Cronbach’s alphas
ranging from 0.75 to 0.87, and good model fit through confirmatory factor analysis
(Bohlmeijer, ten Klooster, Fledderus, Veehof, & Baer, 2011). Most of the FFMQ-SF
subscales demonstrated adequate internal consistency in the current sample (observing,
a=0.84; describing, a=0.84; acting with awareness, a=0.74; nonreactivity to inner
experience, a=0.67). However, the subscale of nonjudging of inner experience
demonstrated unsatisfactory internal consistency in the current sample, a=0.47.
Functional Assessment of Cancer Therapy – General (FACT-G)
The FACT-G (Cella, D. F., Tulsky D. S., Gray G., Sarafian B., Lloyd S., et al.,
1993) is a 27-item questionnaire that assesses for four domains of health-related quality
of life in cancer patients. Quality of life domains include physical, social, emotional, and
functional wellbeing. Items are rated on a 5-point Likert scale, ranging from not at all (0)
to very much (4). Items are reversed scored as indicated. Items that correspond to each
domain are summed to obtain a subscale score. To account for any missing items, the
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subscale score is multiplied by the number of items in the subscale and then divided by
the number of items answered. Subscale scores can also be summed to derive a total
FACT-G score. The higher the score, the better quality of life. The FACT-G has
demonstrated adequate to high internal consistency in samples of patients diagnosed with
various types of cancer (a=0.69-0.82; Cella, Tulsky, Gray, Sarafian, Lloyd, et al., 1993)
and samples of patients diagnosed with breast cancer (a=0.78-0.90; Lee, Chun, Kang, &
Lee, 2004) The FACT-G subscales demonstrated adequate to high internal consistency in
the current sample (physical, a=0.86; social, a=0.77; emotional, a=0.79; functional,
a=0.90).
Treatment Preferences
Questions used to assess participants’ treatment preferences were adopted and
modified from Haugh et al. (2019). Participants answered 9 to 24 items based on their
responses and skip logic. Participants were first provided with a description of a SCM as
outlined by Broten, Naugle, Kalata, and Gaynor (2011). Participants were then provided
with a description of each step and treatment(s) within each step of the defined SCM.
Following each description, participants were asked to rate how acceptable they
perceived treatments to be on a 5-point Likert scale, ranging from not acceptable (1) to
very acceptable (5).
Participants who rated certain treatments to be at least slightly acceptable (e.g., a
rating of 2 or above) were asked additional questions based on the treatment. For
example, participants who rated self-help to be at least slightly acceptable were also
asked whether they would prefer guided or unguided self-help and whether they would
prefer self-help delivered via books, mobile applications, or internet-based programs. For
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all items pertaining to preference, participants were asked to rate the strength of
preference on a 5-point Likert scale ranging from not strong (1) to very strong (5).
Finally, participants were asked to indicate which step and treatment they would prefer to
start with if seeking help for psychological symptoms and the strength of that preference.
Demographic, Medical, and Psychological History
With regards to demographic information, participants were asked to indicate
their age, ethnicity, race, and income. With regards to medical information, participants
were asked to indicate their stage of cancer diagnosis and any active, ongoing, or past
treatment. With regards to psychological information, participants were asked to indicate
any psychiatric history, including diagnosis and treatment.
Procedure
Participants were recruited through an ambulatory oncology center located in the
Northeastern United States. Potential participants were identified with the help of the
research coordinator, medical service assistants, and certified nursing assistants within
the clinic. To identify potential participants, some demographic information was gathered
prior to patient consent; however, information was protected under the oncology center’s
Health Insurance Portability and Accountability Act (HIPAA). Patients were approached
in one of three ways: (1) either prior to or shortly following their scheduled appointment
with their oncologist, (2) while getting chemotherapy in the treatment suite, or (3) getting
vitals and/or blood work for upcoming treatment. Once approached, patients were
provided with information about the study, including rationale and purpose, and asked to
participate in the baseline survey. Electronic informed consent was obtained from those
who agreed. Participants were asked to complete the PHQ-9 and GAD-7 via paper and
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pencil, which allowed on-site researchers to score and determine additional eligibility for
the bibliotherapy. Participants were then provided with an iPad and asked to complete the
IPQ-B, CD-RISC 10, FFMQ-SF, and FACT-G electronically via the online survey-based
platform of Qualtrics. Items to assess demographic, psychological, and medical history as
well as treatment preferences questionnaire were also completed at time of consent.
Following completion of the baseline survey, patients who were eligible for the
bibliotherapy were provided with a brief description of the protocol. Full written
informed consent was obtained from those who agreed to participate. Participants were
provided with a pre-paid paperback copy of Mindfulness-Based Cancer Recovery: A
Step-by-Step MBSR Approach to Help You Cope with Treatment & Reclaim Your Life
(Carlson & Speca, 2011). Participants were asked to provide their email address to
receive weekly emails, which included weekly guided modules and biweekly surveys
administered through Qualtrics. Included within weekly emails were prompts for
participants to complete the module, any corresponding worksheets, and/or surveys (see
Appendix B). Biweekly surveys included the PHQ-8 (alternative to PHQ-9; Kroenke et
al., 2009), GAD-7, IPQ-B, CD-RISC 10, FACT-G, and FFMQ-SF. To reduce respondent
fatigue, participants had the option to complete measures at the same time or at separate
times during the week. Finally, participants were emailed one month following
completion in the eight-week protocol and asked to complete follow-up surveys.
Data Analysis
Data analyses will be conducted using IBM SPSS Statistics (version 28.0.1.1).
Quantitative analyses consisted of descriptive data pertaining to the baseline survey (e.g.,
SCM acceptability rates, treatment preferences, and strength of preferences) and
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feasibility rates for eligibility, consent, and completion. Qualitative analyses consisted of
behavioral observations within the clinic, reasons provided for declining participation in
the survey, reasons for declining participation in the bibliotherapy, and reasons for
withdrawing from the bibliotherapy. Information on modifications created and approved
throughout active recruitment were also provided and discussed.

24

Chapter 3
Results
Active Recruitment Timeline
The current study was approved by the oncology clinic’s Institutional Review
Board (IRB) on February 8th, 2021. Researchers included the principal investigator (PI)
and research assistants (RAs). In addition to the PI, three RAs were approved to conduct
in-person data collection following IRB review. The RAs were trained and observed by
the PI prior to collecting data on their own. Per our available personnel resources, on-site
researchers were able to actively recruit from March 23rd, 2021, to February 4th, 2022
(approximately 46 weeks). The modal number of researchers in the clinic at any given
time was one. Total recruitment in the clinic spread a total of 49 days (approximately
1.07 times per week), with a total of 166 hours of time spent in active recruitment.
Primary Outcome
Feasibility
Target feasibility estimates and actual percentages are presented in Figure 2.
Feasibility was considered achieved if actual percentages were within 5% of the target
estimate. Targets were estimated based on Zernicke et al. (2014); a previous feasibility
study for an online MBCR eTherapy program. Feasibility was assessed through the
following: a) proportion of patients approached for baseline survey (estimate of 30%);
target was not met with 96 patients (21.3%), b) proportion of patients who consented to
participate in baseline survey (estimate of 85%); target was not met with 45 patients
(46.9%), c) proportion of patients eligible for bibliotherapy (estimate of 30%); target was
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met with 32 patients (55.2%), d) proportion of patients who consented to participate in
the bibliotherapy (estimate of 85%); target was not met with 10 patients (31.3%), and e)
proportion of participants who completed each time point in the bibliotherapy protocol
(estimates of 85% for each); target was not met at T2 and T4 (30% and 33.3%,
respectively), but met at T3, T5, and T6 (100%).

26

Figure 2
Feasibility and Target Rates Flow Diagram
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Baseline Survey
Total Patients Approached for Baseline Survey
The oncology clinic’s research coordinator screened appointments and identified
potential participants through our basic inclusion criteria. A total of 451 patient names
were provided across the data collection period mentioned previously. Any additional
ineligibility through further examination was determined as well as whether patients were
appropriate to approach. A total of 17 patients were ineligible upon further screening.
Reasons for ineligibility included English not being the patient’s primary language
(Spanish- or Greek-speaking; n=10), the patient being part of a special population (age
>90, identified neurocognitive impairment; n=4), or breast cancer not being the patient’s
primary cancer site (n=3).
In addition to ineligibility, a total of 338 patients were not appropriate to
approach. The most frequent reason that a patient was not approached was if they were a
repeat patient (n=146). In other words, the patient had been previously approached and
they either a) participated, b) declined participation, or c) was previously determined to
be ineligible. At times, researchers were unable to approach patients due to our own
resources pertaining to researcher availability (n=87). More specifically, this was
categorized if a) the on-site researcher missed the patient as they were obtaining consent
or administering the study to another patient, b) the researcher was out of the office due
to personal constraints and/or illness, or c) there was not enough time to approach given
proximity to office closure. Researchers were unable to approach patients if they no
showed/rescheduled their appointment (n=36) or if they were scheduled for a telehealth
appointment (n=29). At times, researchers did not approach patients based on the
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provider’s discretion. Reasons included (per providers) perceived acute distress during
appointment (n=20), if the patient’s age and functional status were perceived as barriers
to completing participation (n=12), or if the patient expressed not feeling well to the
provider (n=8). In sum, researchers approached a total of 96 patients (21.3%) during
active recruitment.
Reasons for Declining Participation in Survey
Of the 96 patients approached during active recruitment, 51 patients (53.13%)
ultimately did not consent to participate in the baseline survey. Some patients (n=16)
politely declined and did not provide any spontaneous information for not wanting to
participate, while others provided information about their decision to decline. Of note,
some patients offered multiple reasons. The most common reason patients expressed was
not having enough time either prior to or following their appointment to complete the
approximately 20-to-25-minute survey (n=20). Some patients denied a perceived need or
benefit to participate given their distress had been either minimal or manageable (n=13).
On the other hand, a similar number of patients declined as they reported too much acute
emotional and/or physical distress (n=12). At times, patients also reported difficulty using
the iPad technology provided to complete the survey (n=7). One patient acknowledged
recent experience with depression and anxiety; however, she reported her distress was
pandemic-related and not secondary to or exacerbated by her breast cancer; as such, she
politely declined participation.

29

Stepped-Care Model (SCM)
Treatment Acceptability at Baseline
Participants who completed the baseline survey (N=40) on average indicated the
SCM to be a moderately acceptable to acceptable treatment approach for depression and
anxiety (M=3.78, SD=0.95, mode=4). In addition, participants on average viewed the
SCM to be a probable improvement upon standard care for mental health treatment
(M=3.85, SD=0.92, mode=4). Similarly, those who also consented to participate in the
current bibliotherapy (n=10) on average indicated the SCM to be an acceptable treatment
approach for depression and anxiety (M=4.00, SD=1.25, modes=4 and 5). In addition,
participants on average viewed the SCM to be a probable improvement upon standard
care for mental health treatment (M=3.60, SD=1.43, mode=4). Please see Table 2 for full
description of acceptability ratings for the specific treatments offered within the SCM.

Table 2
Participant Treatment Acceptability Ratings within the SCM
Total (N=40)
MBCR Subsample (n=10)
Treatment (Step)

M (SD)

M (SD)

Psychoeducation (2)

3.80 (0.99)

4.10 (1.29)

Self-Help (2)

3.70 (1.14)

4.00 (1.25)

Medication (3)

3.60 (1.24)

3.60 (1.51)

Combined P&M(a) (3)

3.50 (1.34)

3.20 (1.62)

Psychotherapy (3)

3.43 (1.36)

2.80 (1.62)

Watchful Waiting (1)

2.95 (1.32)

3.40 (1.51)

Inpatient Programs (4)

2.70 (1.36)

2.80 (1.48)

IOP/PHP(b) (4)

2.58 (1.36)

2.70 (1.49)

Note. (a) Combined P&M = Combined Psychotherapy and Medication; (b) IOP/PHP =
Intensive Outpatient Programs/Partial Hospitalization Programs.
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Treatment Preferences at Baseline
Unless treatments were indicated as not acceptable, participants were asked to
indicate their preferred format, type, and modality for certain treatments (e.g., self-help,
medication, psychotherapy). Regarding self-help (n=38), participants most frequently
indicated preference for guided (n=32, 84.2%) compared to unguided (n=6, 15.8%) and
books (n=20, 52.6%) compared to internet-based programs (n=14, 36.8%) or mobile
applications (n=4, 10.5%). Strength of preference for guided versus unguided as well as
type of self-help was moderately strong to strong (M=3.66, SD=1.05, modes=3.00 and
4.00; M=3.61, SD=0.97, mode=4.00, respectively). Regarding psychotherapy (n=35),
participants most frequently indicated preference for problem-solving therapy (n=13,
37.1%), followed by cognitive therapy (n=8, 22.9%), mindfulness-based therapy (n=7,
20%), interpersonal therapy (n=5, 14.3%), and behavioral activation (n=2, 5.7%).
Strength of preference was moderately strong (M=3.49, SD=1.04, mode=3.00).
All participants (N=40) were also asked to indicate the step of the SCM they
would prefer to start with if seeking mental health treatment. Participants most frequently
indicated preference for Step 3 (n=17, 42.5%), followed by Step 2 (n=10, 25%), Step 1
(n=9, 22.5%), and Step 4 (n=4, 10%). Overall strength of preference was moderately
strong to strong (M=2.70, SD=0.68, modes=3.00 and 4.00). Please see Table 3 for
preferred treatments within each step and corresponding strength of preference. Similarly,
those who consented to participate in the bibliotherapy (n=10) most frequently indicated
preference for Step 3 (n=6, 60%), followed by Step 2 (n=2, 20%), and then Step 1 (n=1,
10%) or Step 4 (n=1, 10%). Overall strength of preference was strong (M=3.90, SD=1.20,
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mode=5.00). Please see Table 4 for preferred treatments within each step and
corresponding strength of preference.

Table 3
Preferences and Strength of Preferences for Treatments (N=40)
Step
TWS(a)
Strength of Preference
Treatments
Step 1

n (%)

n (%)

9 (22.5)

Watchful Waiting
Step 2

M

SD

3.00

1.58

2.90

1.20

9 (22.5)
10 (25)

Combined P&S(b)

8 (80)

3.50

0.93

Psychoeducation

1 (10)

2.00

0.00

Self-Help

1 (10)

4.00

0.00

3.82

0.95

Step Three

17 (42.5)

Combined P&M(c)

11 (64.7)

4.09

1.04

Medication

4 (23.5)

3.25

1.26

Psychotherapy

2 (11.8)

4.00

1.41

4.00

0.82

Step Four

4 (10)

IOP/PHP(d)

3 (75)

3.67

1.16

Inpatient Programs

1 (25)

4.00

0.00

Note. (a) TWS = Treatment Within Step; (b) Combined P&S = Combined Psychoeducation
and Self-Help; (c) Combined P&M = Combined Psychotherapy and Medication; (d)
IOP/PHP = Intensive Outpatient Programs/Partial Hospitalization Programs.
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Table 4
Preferences and Strength of Preferences for Treatments (n=10)
Step
TWS(a)
Strength of Preference
Treatments

n (%)

Step 1

1 (10)

Watchful Waiting
Step 2

n (%)

M

1 (10)

5.00

2 (20)

SD

3.00

Combined P&S(b)

2 (100)

3.00

Psychoeducation
Self-Help
Step Three

6 (60)

4.17

1.33
1.41

Combined P&M(c)

5 (83.3)

4.00

Medication

1 (16.7)

3.00

Psychotherapy
Step Four

1 (10)

3.00

IOP/PHP(d)

1 (100)

3.00

Inpatient Programs
Note. (a) TWS = Treatment Within Step; (b) Combined P&S = Combined Psychoeducation
and Self-Help; (c) Combined P&M = Combined Psychotherapy and Medication; (d)
IOP/PHP = Intensive Outpatient Programs/Partial Hospitalization Programs.

Modifications
A total of four modifications were submitted throughout active recruitment.
Modifications were based on researcher observations in the clinic that perceptively
impacted overall recruitment as well as eligibility for the current bibliotherapy. The first
modification (approved 4/08/21) allowed researchers to distribute a flyer to patients and
providers. The flyer included a brief description of the study and PI contact information.
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No additional correspondence via email or phone following the creation and approval of
the flyer were received.
The second modification (approved 5/07/21) was focused on those who consented
to participate in the current bibliotherapy. First, questions were added to weekly surveys
to collect qualitative data from patients (e.g., What did you like most about the
readings?). Reminder emails were also created to send participants each week to further
prompt completion of modules/surveys and provide augmented space for participants to
email the PI with questions or concerns (see Appendix B). Third, participants were asked
to complete the FFMQ-SF and CD-RISC 10 monthly rather than biweekly.
The third modification (approved 7/01/21) focused on altering the exclusion
criteria for the current bibliotherapy. With regards to symptomatology, the original
criteria excluded those a) experiencing minimal or severe levels of depression and
anxiety, and/or b) endorsing suicidal ideation as indicated by item 9 on the PHQ-9. The
criteria were modified to only exclude patients experiencing suicidal ideation as indicated
through item 9 on the PHQ-9 as well as meeting a moderate or high risk via assessment
with the Columbia Suicide Severity Scale (CSSR-S). Prior to our third modification,
patients were only presented with information pertaining to the bibliotherapy if they were
determined eligible to participate. Prior to modification approval, 21 out of the 25
patients (84%) who had participated in the baseline survey were determined to be
ineligible for the bibliotherapy due to symptom endorsement on the PHQ-9 and GAD-7.
As a result, these 21 patients were not presented with any information on the
bibliotherapy or the option to participate in the protocol further.
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The fourth modification (approved 10/13/21) allowed researchers to reapproach
those who participated in the baseline survey and were determined to not be eligible to
participate in the bibliotherapy due to prior exclusion criteria. In addition, approval was
obtained for an additional researcher to assist with data collection.
MBCR Bibliotherapy
Eligibility and Interest in Bibliotherapy
A total of 58 patients were further examined to determine eligibility for
participation in the bibliotherapy. Twenty-six patients (44.8%) were determined to be
ineligible. The most common reason was symptom endorsement on the PHQ-9 and/or
GAD-7 mentioned previously (n=21). Following approval of the modification to alter
exclusion criteria, the remaining five patients were ineligible for various reasons. Two
patients disclosed histories of substance abuse, one patient was previously diagnosed with
a schizophrenia spectrum disorder, one patient was currently receiving psychotherapy,
and one patient only partially completed the baseline survey due to lack of time.
A total of 32 patients (55.2%) were eligible for the bibliotherapy and were
presented with a brief description of the protocol. The brief description included
information regarding a) the expectations for participation (e.g., weekly readings,
biweekly surveys, assignments within each module), b) the rationale underlying the use
of bibliotherapy, and c) a mindfulness-based approach. Twenty-two patients (68.7%)
ultimately declined to participate in the bibliotherapy. Some patients politely declined
without spontaneously providing information or reasons as to why (n=4). A total of 18
patients provided additional information regarding their decision to decline. Of note,
patients tended to provide multiple reasons. One common reason reported was not having
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enough time to dedicate to the protocol (n=9). Another equally common reason was they
stated the bibliotherapy was not a good fit for them (n=9). For example, goodness of fit
was categorized when patients reported a) adequate coping through established strategies
and/or strong social support, or b) when their distress was not related to their breast
cancer (e.g., occupational stress, pandemic-related stress). Less frequently, patients
reported not being well-versed in or technologically savvy enough (n=3) and one patient
expressed preference an internet-based program. Finally, one patient reported reading
would be a strain for her due to a recent cerebrovascular accident.
Consent and Participation in Bibliotherapy
Of the 32 patients eligible for participation in the bibliotherapy, consent was
obtained from a total of 10 patients (31.3%). Of those, 7 participants (70%) did not
proceed past the baseline survey. Some patients withdrew from the study (n=4), while
others simply did not reply to weekly emails and did not take any of the biweekly surveys
(n=3). While two patients did not provide reason or information underlying their
withdrawal, two participants reported time constraint and increased stress underlying
their desire to withdraw. Two of the three participants who did not reply to weekly emails
or biweekly surveys expressed concerns with using technology during participation in the
baseline survey.
Three of the 10 patients (30%) who consented to participate in the bibliotherapy
proceeded past the baseline survey. Regarding attrition, two participants (66.7%) did not
proceed past week four (Time 3) of the eight-week protocol. Participant one dropped out
and reported she was unable to complete the readings and practices in the self-help book
because she was “not feeling well due to new medication.” Participant two dropped out
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and did not provide additional information. Participant three completed the full eightweek protocol, biweekly surveys, and the one-month follow-up survey. See Tables 5-7
for full description of measurement-based scores for each participant throughout the
study.

Table 5
Participant One(a) Data During MBCR Bibliotherapy Protocol
Baseline
Time 2
(Time 1)
(Week 2)
Measure

Time 3
(Week 4)

Score (of total)

Score (of total)

Score (of total)

PHQ-9/PHQ-8(b)

12 (27)

5 (24)

2 (24)

GAD-7

6 (21)

5 (21)

2 (21)

IPQ-B

33 (80)

36 (80)

11 (80)

CD-RISC 10

24 (40)

24 (40)

FFMQ-SF (total)

67 (120)

78 (120)

Observing

14 (20)

15 (20)

Describing

10 (25)

14 (25)

Acting w/ Awareness

17 (25)

18 (25)

Nonjudgment

13 (25)

15 (25)

Nonreactivity

13 (25)

16 (25)

FACT-G

75 (108)

74 (108)

95 (108)

Physical

15 (28)

20 (28)

22 (28)

Social

26 (28)

12 (28)

26 (28)

Emotional

19 (24)

20 (24)

23 (24)

Functional

15 (28)

22 (28)

24 (28)

Note. (a) Participant dropped-out of study following Time 3 (Week 4). (b) The
PHQ-9 was replaced by the PHQ-8 following baseline.
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Table 6
Participant Two(a) Data During MBCR Bibliotherapy Protocol
Baseline
Time 2
(Time 1)
(Week 2)
Measure

Time 3
(Week 4)

Score (of total)

Score (of total)

Score (of total)

PHQ-9/PHQ-8(b)

2 (27)

2 (24)

0 (24)

GAD-7

0 (21)

0 (21)

2 (21)

IPQ-B

39 (80)

34 (80)

33 (80)

CD-RISC 10

23 (40)

21 (40)

FFMQ-SF (total)

76 (120)

91 (120)

Observing

15 (20)

17 (20)

Describing

16 (25)

19 (25)

Acting w/ Awareness

18 (25)

22 (25)

Nonjudgment

14 (25)

15 (25)

Nonreactivity

13 (25)

18 (25)

FACT-G

75 (108)

92.33 (108)

100.67 (108)

Physical

18 (28)

23 (28)

25 (28)

Social

18 (28)

23.33 (28)

25.67 (28)

Emotional

17 (24)

22 (24)

22 (24)

Functional

22 (28)

24 (28)

28 (28)

Note. (a) Participant dropped-out of study following Time 3 (Week 4). (b) The
PHQ-9 was replaced by the PHQ-8 following baseline.
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Table 7
Participant Three(a) Data During MBCR Bibliotherapy Protocol
Baseline
Time 2
Time 3
Time 4
(T1)
(Wk 2)
(Wk 4)
(Wk 6)

Time 5
(Wk 8)

Time 6
(Wk 12)

Measure

Score
(total)

Score
(total)

Score
(total)

Score
(total)

Score
(total)

Score
(total)

PHQ-9/8(b)

0 (27)

0 (24)

0 (24)

0 (24)

0 (24)

0 (24)

GAD-7

0 (21)

0 (21)

0 (21)

0 (21)

0 (21)

0 (21)

IPQ-B

0 (80)

0 (80)

0 (80)

0 (80)

8 (80)

18 (80)

CD-RISC 10

40 (40)

40 (40)

39 (40)

39 (40)

FFMQ-SF

84 (120)

99 (120)

110 (120)

98 (120)

Observing

14 (20)

20 (20)

20 (20)

20 (20)

Describing

19 (25)

21 (25)

25 (25)

23 (25)

Awareness

21 (25)

25 (25)

25 (25)

21 (25)

Nonjudgment

13 (25)

13 (25)

19 (25)

10 (25)

Nonreactivity

17 (25)

20 (25)

21 (25)

24 (25)

80 (108)

80 (108)

FACT-G

108 (108)

76 (108)

108 (108) 108 (108)

Physical

28 (28)

28 (28)

28 (28)

28 (28)

28 (28)

28 (28)

Social

28 (28)

28 (28)

28 (28)

28 (28)

0 (28)

28 (28)

Emotional

24 (24)

20 (24)

24 (24)

24 (24)

24 (24)

24 (24)

Functional

28 (28)

0 (28)

28 (28)

28 (28)

28 (28)

0 (28)

Note. (a) Participant score patterns throughout study evidence a tendency of extreme
response bias. (b) The PHQ-9 was replaced by the PHQ-8 following baseline. Awareness
= Acting with Awareness; T1 = Time 1; Wk = Week.

Treatment Progress and Outcomes
Participant One
Depression and Anxiety. When participant one completed the PHQ-9 in the
clinic with the on-site researcher, they endorsed a score of 12 out of a possible 27, which
indicates a moderate level of depressive symptoms. During the four-week period
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participant one adhered to the study protocol, they experienced a 10-point decrease. A
score of 2 indicates a minimal level of depressive symptoms. When participant one
completed the GAD-7 in the clinic with the on-site researcher, they endorsed a score of 6
out of a possible 21, which indicates a mild level of anxiety symptoms. During the fourweek period, participant one experienced a four-point decrease. A score of 2 indicates a
minimal level of anxiety symptoms. See Figure 3 for scores throughout the study.

Figure 3
Participant One, PHQ-9 and GAD-7 Scores
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Mindfulness. When participant one completed the FFMQ-SF in the clinic with
the on-site researcher, they endorsed moderate levels of mindfulness with a total score of
67 out of a possible 120. Scores on the five mindfulness subscales ranging from 10 to 17.
During the four-week period, participant one experienced an 11-point increase in their
endorsed level of mindfulness with a score of 78 out of a possible 120. See Figure 4 for
scores throughout study.
40

Figure 4
Participant One, FFMQ-SF Scores
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Quality of Life. When participant one completed the FACT-G in the clinic with
the on-site researcher, they endorsed moderate to high quality of life with a total score of
75 out of a possible 108. Scores on the four quality of life subscales ranged from 15 to
26. During the four-week period, participant one experienced a 20-point increase in their
endorsed quality of life with a score of 95 out of a possible 108. See Figure 5 for scores
throughout study.
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Figure 5
Participant One, FACT-G Scores
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Resilience. When participant one completed the CD-RISC 10 in the clinic with
the on-site researcher, they endorsed a moderate level of resilience with a score of 24 out
of a possible 40. During the four-week period, participant one’s level of resilience
remained stable.
Illness Perception. When participant one completed the IPQ-B in the clinic with
the on-site researcher, they endorsed a mild to moderately threatening perception of their
illness with a score of 33 out of a possible 80. During the four-week period, participant
one experienced a 20-point decrease with a score of 11 out of a possible 80. See Figure 6
for scores throughout study.
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Figure 6
Participant One, IPQ-B Scores
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Participant Two
Depression and Anxiety. When participant two completed the PHQ-9 in the
clinic with the on-site researcher, they endorsed a score of 2 out of a possible 27, which
indicates a minimal level of depressive symptoms. During the four-week period
participant two adhered to the study protocol, they experienced a two-point decrease. A
score of 0 indicates no depression. When participant two completed the GAD-7 in the
clinic with the on-site researcher, they endorsed a score of 0 out of a possible 21. During
the four-week period, participant two experienced a two-point increase. A score of 2
indicates a minimal level of anxiety symptoms. See Figure 7 for scores throughout the
study.
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Figure 7
Participant Two, PHQ-9 and GAD-7 Scores
2.5
2

2

2

0

0

0

Time 1

Time 2

Time 3

2

1.5

1

0.5

0

PHQ

GAD-7

Mindfulness. When participant two completed the FFMQ-SF in the clinic with
the on-site researcher, they endorsed moderate to high levels of mindfulness with a total
score of 76 out of a possible 120. Scores on the five mindfulness subscales ranged from
13 to 18. During the four-week period, participant two experienced a 15-point increase in
their endorsed level of mindfulness with score of 91 out of a possible 120. See Figure 8
for scores throughout study.
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Figure 8
Participant Two, FFMQ-SF Scores
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Quality of Life. When participant two completed the FACT-G in the clinic with
the on-site researcher, they endorsed moderate to high quality of life with a total score of
75 out of a possible 108. Scores on the four quality of life subscales ranged from 18 to
22. During the four-week period, participant two experienced an approximately 25-point
increase in their endorsed quality of life with a score of 100.67 out of a possible 108. See
Figure 9 for scores throughout study.
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Figure 9
Participant Two, FACT-G Scores
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Resilience. When participant two completed the CD-RISC 10 in the clinic with
the on-site researcher, they endorsed a moderate level of resilience with a score of 23 out
of a possible 40. During the four-week period, participant two experienced a two-point
decrease with a score of 21 out of a possible 40. See Figure 10 for scores throughout the
study.
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Figure 10
Participant Two, CD-RISC 10 Scores
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Illness Perception. When participant two completed the IPQ-B in the clinic with
the on-site researcher, they endorsed moderately threatening perception of their illness
with a score of 39 out of a possible 80. During the four-week period, participant two
experienced a six-point decrease with a score of 21 out of a possible 80. See Figure 11 for
scores throughout study.
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Figure 11
Participant Two, IPQ-B Scores
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Participant Three
Depression and Anxiety. When participant three completed the PHQ-9 in the
clinic with the on-site researcher, they endorsed a score of 0, which indicates no
depressive symptoms. During the twelve-week period, participant three remained stable
with regards to self-report depressive symptoms (score of 0). When participant three
completed the GAD-7 in the clinic with the on-site researcher, they endorsed a score of 0,
which indicates no anxiety symptoms. During the twelve-week period, participant three
remains stable with regards to self-report anxiety symptoms (score of 0).
Mindfulness. When participant three completed the FFMQ-SF in the clinic with
the on-site researcher, they endorsed high levels of mindfulness with a total score of 84
out of a possible 120. Scores on the five mindfulness subscales ranged from 14 to 21.
During the eight-week period while participating in the bibliotherapy, participant three
experienced a 26-point increase with a score of 110 out of a possible 120. When assessed
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at one month follow-up, participant three experienced a 12-point decrease with a score of
98 out of a possible 120, though high levels of mindfulness were maintained. See Figure
12 for scores throughout study.

Figure 12
Participant Three, FFMQ-SF Scores
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Quality of Life. When participant three completed the FACT-G in the clinic with
the on-site researcher, they endorsed the highest level of quality of life with a total score
of 108 out of a possible 108. Scores on the four quality of life subscales ranged from 24
to 28. During the twelve-week period, participant three’s scores remained somewhat
stable; however, score patterns evidenced a tendency for participant three to engage in
extreme response bias for this measure. For example, participant three indicated no
functional quality of life with a score of 0 at Time 2 (week two) and one-month followup; however, participant three indicated the highest level of functional quality of life with
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a score of 28 out of a possible 28 at Time 3 (week four), Time 4 (week six), and Time 5
(week eight). See Figure 13 for scores throughout study.

Figure 13
Participant Three, FACT-G Scores
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Resilience. When participant three completed the CD-RISC 10 in the clinic with
the on-site researcher, they endorsed the highest level of resilience with a score of 40 out
of a possible 40. During the twelve-week period, participant three’s resilience scores
remained relatively stable. However, at Time 5 (week eight) and one-month follow-up,
participant three indicated a one-point decrease (i.e., score of 39 across both time points).
Illness Perception. When participant three completed the IPQ-B in the clinic with
the on-site researcher, they did not endorse a threatening perception of their illness as
indicated by a score of 0. During the twelve-week period, participant three experienced
an 18-point increase with a score of 18 out of a possible 80. See Figure 14 for scores
throughout study.
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Figure 14
Participant Three, IPQ-B Scores
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Patient Feedback while Participating in the Bibliotherapy
Following approval for the second modification, patients participating in the
bibliotherapy (n=3) were asked to provide feedback through open-ended questions
included in each biweekly survey. Open-ended questions assessed for any barriers or
difficulties patients experienced when attempting to complete the assigned readings, what
patients liked most about the readings, what patients liked least about the readings, and
any difficulties patients experienced while attempting to engage in the mindfulness-based
practices. Please see Table 8 for full descriptions of the feedback each participant
provided during each time point.
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Chapter 4
Discussion
Target Rates for Feasibility
The trial is the first to assess the feasibility of implementing a guided MBCR
bibliotherapy program to women with breast cancer in an ambulatory oncology clinic.
The current study met the estimated target rate for patients eligible for the bibliotherapy
(55.2%) and found evidence of retention throughout the bibliotherapy protocol. However,
many of the other estimated target rates set for eligibility (i.e., total patients approached
for baseline survey), consent, and completion were not met. As a result, feasibility as
defined through meeting estimated target rates was not supported. However, a variety of
additional areas of focus were considered within feasibility. As discussed previously,
these areas were defined by Bowen et al. (2009) and Gadke, Kratochwill, and Gettinger
(2021). In addition to estimated target rates, the behavioral observations during
recruitment and qualitative data have shed light on these other areas of focus (e.g.,
acceptability, recruitment capacity, etc.).
Areas of Focus and Future Directions
Acceptability
As expected, based on previous literature (Broten, Naugle, Kalata, & Gaynor,
2011; Haugh et al., 2019; O’Donohue & Draper, 2011), results continued to suggest that
the SCM is viewed to be an acceptable treatment approach and a probable improvement
upon standard care. Regarding individual treatments within the SCM, psychoeducation
and self-help had the highest acceptability ratings. Moreover, patients most frequently
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indicated preference for guided versus unguided self-help and self-help books (i.e.,
bibliotherapy) versus internet-based programs or mobile applications. Taken together,
these preferences supported the decision to use a guided bibliotherapy for the current
study. On the other hand, with regards to the focus of MBCR, results for the baseline
survey suggest patients tended to prefer a problem-solving or cognitive approach versus a
mindfulness-based approach. Considering the importance of patient preference to
treatment adherence and satisfaction (Carlson et al., 2017; Iacoviello et al., 2007), it
might have been beneficial to present patients with the option to choose a guided
bibliotherapy based on their preferred modality or theoretical orientation.
The research collaboration established prior to the current study was invaluable to
efforts to recruit and retain participants. The study – in its entirety – was positively
received among the research coordinators, providers, nurses, and staff. In addition to
being welcomed and accommodated while on-site, there were immediate affirmations
untoward the rationale for using a guided MBCR bibliotherapy. It soon became evident
that treatments for addressing psychological distress within this context were limited. As
such, the protocol was perceived by providers and staff as appropriate as well as a good
fit within the organizational culture.
Recruitment Capacity
A total of 451 patients were identified for participation by the clinic’s research
coordinator for the baseline survey. Of those, only 17 patients were ineligible through
further screening. However, an additional 338 patients were not appropriate for
researchers to approach. The most overwhelming reason patients were not approached
was if the patient was a repeat (i.e., already participated or declined). Based on census
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data, the clinic saw 98 new patients diagnosed with breast cancer in 2020. While the
census was projected to increase following the initial height of the COVID-19 pandemic,
the clinic experienced a rise in COVID-19 related cases during December 2021 to
February 2022. As a result, many of the in-person appointments were transitioned to
telehealth. The researchers of the current study were able to approach a total of 96
patients for potential participation in the baseline survey, which aligned closely to the
number of new patients seen in in the clinic during 2020.
Overall, the pandemic has largely reshaped the research landscape (Ramos, 2021).
As time progresses, future researchers will likely continue to learn how to navigate
pandemic-related challenges and increase flexibility in research protocols. Our initial
rationale to have patients complete the baseline survey on-site was the written informed
consent required for participation in the bibliotherapy. As those receiving oncological
treatments (e.g., chemotherapy) have compromised immune systems, it would be
beneficial to explore alternative options. Specifically, future research might consider
ongoing discussion and inquiry from the Institutional Review Board (IRB). In addition,
The Food & Drug Administration (FDA) published guidance for investigators when
conducting clinical trials for medical products during the COVID-19 public health
emergency (FDA, 2021). While these guidelines pertain specifically to medical products,
answering whether it might be appropriate to obtain consent via phone call or video
conference in this population is warranted given potential vulnerability.
With regards to identifying patients with the potential of benefiting from
participation in the bibliotherapy, the estimated target eligibility rate (55.2%) was met.
However, the proportion decreases to 33.3% when those who were eligible (n=32) are
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compared with the total number of patients approached for the baseline survey (n=96).
Ideally, researchers for the current study would have been able to present and provide the
opportunity for all new patients to take part in the bibliotherapy. Attempts were made to
be mindful of previous literature as well as what was learned during our prior research
(Haugh et al., 2019). For example, literature has recommended including the use of
physician recruiters and building personal connections with the providers and staff within
the clinic (Johnston et al., 2010). The first modification assisted with effective
communication with providers. Specifically, the creation of the flyer allowed us to easily
describe the rationale for the study and discuss expectations for participation. In addition,
many providers in the clinic asked on-site researchers to check-in prior to approaching
patients. Through this additional check-in, the on-site researchers were able to reiterate
the current study more frequently, make presence known, and form more meaningful
connections. The providers were also able to review their scheduled patients for the day
and inform the researchers which of their patients would be appropriate to approach.
Demand and Data Collection
On-site researchers approached a total of 96 patients to ask about willingness to
participate in the baseline survey and the response rate was 46.9%. Results indicated the
most common reason patients declined was they did not have the time required to
participate (n=20). Many of these patients initially expressed interest per researcher
observations (e.g., “Patient politely declined as she did not have the time; receptive to
reapproach at a later date.”). In addition, some patients reported willingness to take the
baseline survey at home if it was offered online (e.g., “Patient mentioned being willing to
provide email and identifying info to set up time for her to come in for the survey…She
57

also mentioned if it was available online then she would have gladly taken a link.”).
Taken together, our data collection procedures might be one prominent explanation for
low use. The baseline survey took patients approximately 20 to 25 minutes to complete
and some 30+ minutes due to their reading proficiency and/or ability to effectively use
the provided iPad. If patients were eligible and interested in participating in the
bibliotherapy, they would then be there for additional time to learn about the protocol,
sign written consent, and receive materials (e.g., self-help book). Taken together, future
research should explore ways to lessen the participant burden at baseline. This might
include only administering necessary measures; for example, having patients only
complete the FFMQ-SF, FACT-G, CD-RISC 10, and IPQ-B if they were participating in
the bibliotherapy. These measures might have then been administered online at baseline
reducing their time in the clinic.
Likewise, researchers approached a total of 32 patients to ask about their
willingness to participate in the bibliotherapy and the response rate was 31.3%. Results
indicated time constraints were one of the most common reasons reported from those
who declined participation (n=9). In addition, seven of the 10 participants who consented
to the bibliotherapy did not proceed past the baseline survey. Some participants did not
respond to any emails (n=3) and some who withdrew (n=2) did so due to time constraint.
Several attempts to lessen participant burden throughout the bibliotherapy protocol were
made. Specifically, our second modification allowed for participants to complete the
FFMQ-SF and CD-RISC 10 monthly rather than biweekly. The rationale for the
modification was to decrease participant burden as well as to reflect the instructions of
these measurements (i.e., please indicate the statement that best reflects your experience
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“…in the last month” rather than the “…past two weeks”). In addition to time, the use of
technology (e.g., completing surveys via email and online administration) was a concern.
For example, one patient who consented and never responded to emails expressed
difficulty accessing technology (e.g., “Patient discussed only having email access on
phone. We explained what emails will include and patient was receptive to trying.”).
Future research might consider ways to reduce the burden of using technology; for
example, providing paper copies of the weekly modules and ensuring surveys appear
mobile-friendly when accessing Qualtrics.
Design Procedures and Implementation
It is possible some of the challenges faced recruiting participants for the
bibliotherapy can be attributed to the initial inclusion criteria regarding symptomatology.
Out of 26 patients who had completed the baseline survey, 21 patients (80.8%) were not
eligible for the bibliotherapy due to symptom endorsement on the PHQ-9 and GAD-7.
Their symptom endorsement (i.e., minimal symptomatology as indicated by scores <5 or
severe symptomatology as indicated by scores 14+) was the only reason they were
ineligible to participate. Moreover, as these patients were not eligible, they were not
provided with any information on the rationale for using bibliotherapy or how
bibliotherapy might be beneficial.
In response to the low volume of patients appropriate to approach for the
bibliotherapy, attempts were made to improve recruitment efforts through modifications.
Despite having similar eligibility criteria to Zernicke et al. (2014), the results and our
observations indicated the initial criteria were too restrictive. As a result, the parameters
regarding symptom endorsement were altered and expanded. In addition to our desire to
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reach a higher number of patients, the episodic nature of psychological distress within the
context of cancer treatment and survivorship was considered. Specifically, previous
research suggests rates of depression are highest in younger women, within the first year
following diagnosis, while undergoing adjunctive treatment including chemotherapy
and/or surgery, and with recurrence (Burgess et al., 2005; Fann et al., 2008; Hegel et al.,
Pasquini & Biondi, 2006; Miller, Bowen, Croyle, & Rowland, 2009). Taken together,
patients might experience varying levels of distress across the cancer care continuum.
Patients who were not experiencing mild to moderate levels of distress at time of
recruitment may still experience distress either later in treatment or during survivorship
(e.g., fear of recurrence and/or recurrence). Following approval of this modification, onsite researchers were able to offer the opportunity to participate to a total of 28 patients
compared to a total of four patients prior to approval. Unfortunately, the modification for
these changes was not approved until July 2021, approximately halfway through active
recruitment. Future research might initially consider a more inclusive eligibility criteria to
optimize dissemination.
In addition to eligibility, patients who participated in the bibliotherapy were asked
to provide feedback about their experience in the study through open-ended questions.
Specifically, the current study assessed aspects of what participants liked the most and
the least about the reading and/or practices, barriers that prevented participants from
completing the assignments, and any difficulties faced when engaging in the practices.
Results suggest those who received and used the bibliotherapy (n=3) liked the
mindfulness-based content and practices the most (e.g., “Teaching me about being aware
of things around me,” “I like the yoga idea,” “The breathing exercises”). They liked
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needing to follow a schedule and the disconnect between reading the scripts during
practices the least (e.g., “Unused to holding to a schedule, but I did it,” “I didn't like
having to put the book down to do the exercises. It's inconvenient to have go back and
forth to follow steps.”). Much like patient-centered care, future research might
incorporate or allot for additional time within the protocol if necessary. The bibliotherapy
and weekly modules offered the recommendation to record oneself reading the practice
scripts. However, it may also prove to be beneficial to include online video or audio
script resources to aid and further facilitate practice in future research.
Integration
As mentioned previously, the clinic’s providers and staff were welcoming and
accommodating to on-site researchers. To support integration, the perceived fit within the
organization as well as feasibility, sustainability of the intervention, and costs to the
organization must also be considered. To reiterate, the current study did not meet most of
the estimated target rates during active recruitment. In addition to factors already
discussed, it is possible that our own resources negatively impacted recruitment rates.
Specifically, the second most common reason for not approaching patients for the
baseline survey was researcher availability (n=87). This frequently occurred when the onsite researcher missed the patient as they were obtaining consent or administering the
study to another patient. Moreover, during the 46 weeks of active data collection and with
the help of research assistants, we were only able to recruit for 49 days, with a total of
166 hours. Many of these days also consistently fell on the same day of the week (e.g.,
Tuesday or Friday). Future research would need to significantly increase researcher
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availability; for example, having more than one researcher on-site as well as researchers
present multiple times a week and potentially varying times during the day.
In order to make this research more feasible in the future and make treatment be
fully integrated into a clinic, it will be important for providers and staff to be willing and
able to provide guided MBCR without being reliant on the treatment team. There are
certain things about the protocol that make integration logistically possible. First, the
modules are created and can be provided via paper booklet for readers to use with the
self-help book. To determine whether the patient’s distress is appropriate for self-help,
providers might continue to employ widely used screeners for depression (PHQ-9) and
anxiety (GAD-7). Staff could easily utilize their already established protocol for
assessing any expressed suicidal ideation. The clinic’s Oncology Social Worker is
already and would continue to be a practical point of contact for questions and concerns
that arise.
There are also certain things about the protocol that make integration challenging.
First, the Mindfulness-Based Cancer Recovery: A Step-by-Step MBSR Approach to Help
You Cope with Treatment & Reclaim Your Life (Carlson & Speca, 2011) is priced at
roughly ~$20 per paperback copy. Purchasing copies in wholesale would be possible
(e.g., 100 – 499 units at 55% discount rate), though this would be a cost incurred by the
clinic. In addition, a clinic “champion” (Johnston et al., 2010) might be necessary to keep
referring patients to the bibliotherapy protocol. The research coordinator was immensely
helpful throughout our collaboration; however, she is not always on-site and is employed
more specifically within the network’s administrative department. Taken together, these
barriers would need to be discussed and resolved prior to long-term integration.
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Effectiveness
The individual results from participants (n=3) provide preliminary support for the
use of the guided bibliotherapy as a viable treatment option. The following clinical
improvements were reported during participation: a) depressive and anxious
symptomatology either remained stable or decreased, b) total scores and facet scores
(observing, describing, acting with awareness, nonjudgmental evaluation, and
nonreactivity) of mindfulness increased; c) scores for total quality of life and domains of
quality of life (physical, social, emotional, and functional) either increased of remained
stable, d) endorsed resilience increased, and e) perceived illness became less threatening.
Of note, participant three experienced an increase in how threatening she
perceived her illness throughout the study. One possible explanation for this increase
might be related to her endorsed increase in mindfulness. Specifically, being more aware
of her internal and/or external stimuli as they relate to her illness might have led her to
rate certain items higher. For example, her ratings indicated that increases in her
mindfulness ratings corresponded to indicating that her illness affected her less
emotionally than it has previously. In addition, her ratings indicated that increases in her
mindfulness ratings corresponded to an increase sense of control over her illness.
Limitations of the Current Study
As discussed previously, a predominant limitation of the current study was the
number of patients who were appropriate to approach for participation. The access to
patients directly impacted the ability to recruit and retain a sample size adequate to meet
estimated target rates and support feasibility. A multitude of factors contributed to how
our access to patients was limited, such as the ongoing pandemic, our own researcher
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availability and resources, difficulties faced with recruitment capacity, and our data
collection procedures. Discussion has been offered regarding insights into these areas of
focus as well as how future research might resolve and circumvent such limitations.
In addition to these areas, a major limitation lies within the lack of diversity
present within our sample. Every woman who participated in the bibliotherapy protocol
identified as White/Caucasian and Non-Hispanic/Latinx. Numerous health disparities
exist within oncology and, more specifically, for women diagnosed with breast cancer.
For example, Black women experience the highest rate of severe breast cancer and are
more frequently diagnosed with triple negative breast cancer when compared to White,
Hispanic/Latinx, and Asian/Pacific Islander women. While Hispanic/Latinx women
experience lower rates than Black and White women, they experience a higher number of
barriers to screening and more advanced breast cancers than White women. Breast cancer
is also the most common and leading cause of cancer-related death Hispanic/Latinx
women (Yedjou et al., 2020). It is crucial for future research to make efforts to recruit
and accommodate diverse women; for example, those who were not English-speaking
were excluded. However, future research might translate study materials to increase
access and dissemination.
A final limitation pertains to the impact a protocol has on the advantages on selfadministered treatment. As discussed previously, one of the major advantages of using
bibliotherapy is that it is self-administered and able to be completed at one’s own leisure.
A diagnosis of cancer presents the additional burden of time-intensive oncological
treatments and/or frequent medical appointments. One common reason for declining
participation in the bibliotherapy was not having enough time to dedicate to the protocol
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(n=9). Moreover, two participants withdrew from the protocol due to time constraints and
increased stress. Future research might consider flexibility with regards to the burden of a
measurement-based and time-based protocol. For example, exploring additional
qualitative assessment and the option of administering focus groups rather than biweekly
self-report questionnaires. Future research might offer the option for participants to
request breaks if necessary and emphasize the opportunity to return to the protocol when
personal responsibilities have lessened.
Conclusions
During the previous two decades, extensive empirical support and efficacy for the
use of MBCR as an in-person treatment and online eTherapy program has been
established (Blaes et al., 2016; Carlson, 2013; Carlson, 2016; Carlson et al., 2015;
Carlson et al., 2019; Toivonen et al., 2020, Zernicke et al., 2014). For the current study,
many of the indices used to evaluate feasibility did not meet pre-established criteria to
suggest that implementation of the program as designed is feasible. However, there are
several other factors that suggested the use of MBCR delivered via bibliotherapy may be
feasible. Of note was the fact that the treatment had demonstrated efficacy for those that
did enroll. More specifically, participants evidenced decreases in depressive and anxious
symptomatology with roughly four weeks of bibliotherapy use. Participants also reported
increases in resilience, levels of mindfulness, and dimensions of quality of life. Previous
research indicates stable social support can improve emotional and physical wellbeing
(APA, 2019; Uchino, 2009). Moreover, increasing resilience and mindfulness can buffer
against and mitigate future distress through pathways of increasing emotional
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nonreactivity, cognitive flexibility, and acceptance (Bergin & Pakenham, 2016; Creswell
& Lindsay, 2014; Davis & Hayes, 2012).
In closing, it is possible that this treatment remains feasible with the
recommended adjustments that arose from the current attempt at implementation. Taken
together, the use of MBCR as a guided bibliotherapy to treat psychosocial distress in a
population of women with breast cancer remains a viable treatment option, although
significant work moving from viable to realized is still needed. Future research may
utilize (and be mindful) of what was learned from the current study to further support the
feasibility of implementing and integrating MBCR guided bibliotherapy in oncology
clinics for women with breast cancer.
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Appendix A
Weekly Modules

Week One
Please read the following:
•

Chapter One: Mindfulness and Cancer

•

Chapter Two: Stress and Cancer

As you read these chapters:
•

•

Think about how the introduction to mindfulness might relate to your own
experience. While there might be differences and your experience can only be
your own, you might recognize similarities.
Try to pay close attention to how the authors define mindfulness. Ask yourself the
below questions:
o Do you live within the present moment as much as you would like?
____________________________________________________________
o Can you recall times when you feel like you are living in autopilot?
____________________________________________________________
o Can you recall times when your mind has been elsewhere, either in the
past or future rather than in the present?
____________________________________________________________

•

Consider your stress and begin to recognize your own symptoms of stress by
taking the self-assessment on page 21.
o This book is yours! Check off your own symptoms on pages 21 and 22.
Identifying your own symptoms might help you to recognize them even
more when they happen in your daily life. You can also write them here:
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
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Week Two
Please read the following:
•

Chapter Three: Beginning the Program

As you read chapter 3:
•

When you read about intention, attention, and attitude, ask yourself the
following questions:
o Why do I want to do this?
____________________________________________________________
____________________________________________________________
o What is my intention behind learning mindfulness meditation?
____________________________________________________________
____________________________________________________________

•
•

•

Try to maintain an open mind while reading the helpful attitudes, which are
outlines on pages 37 and 38.
Set aside a time to complete Practice 3.1 on page 40, which is: Mindfully Eating
a Raisin. It might be easiest to use a raisin during this practice. However, if you
do not like raisins or do not have any accessible, use something small, edible, and
textured.
o As the authors discuss, you can read the instructions first or read the
instructions as you go through the practice.
After you complete the practice, answer the following questions that the outline:
o What was it like for you to eat a raisin (or chosen food) in this way?
____________________________________________________________
____________________________________________________________
o How did it taste?
____________________________________________________________
____________________________________________________________
o How is it different from the way you usually eat things?
____________________________________________________________
____________________________________________________________
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•

Set aside time to complete Practice 3.2 on page 42, which is: Mindful Breathing.
After you complete the practice, answer the following question the authors
outline:
o What did you notice from doing this practice?
____________________________________________________________
____________________________________________________________

•
•

Focus on how the authors define diaphragmatic breathing or “belly breathing.”
Attempt a few breaths to ensure understanding of this kind of breathing.
Read through Practice 3.3 on pages 47-50, which is: Body Scan. This practice is
longer than Mindfully Eating a Raisin and Mindful Breathing. Perhaps take 15
minutes now to complete this practice.
o After you complete the body scan, notice how you feel. Explore any
potential similarities or differences between your experience and the
example of Sarah on page 50.
____________________________________________________________
____________________________________________________________

•

Create a schedule for yourself this week. Set aside 15 to 30 minutes of time per
day for seven days to practice the body scan. You might practice during a certain
time of day, for example, in the morning or before bedtime.
o Try to stick to your schedule. If you miss a scheduled practice, it is okay!
Try to reschedule for later in the day or complete a morning and nighttime
practice the following day.
o You can use the attached worksheet to create your schedule, or you can
write it in a notebook or planner.
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Week Three
Please read the following:
•

Chapter Four: Responding to Stress

•

Chapter Five: Mindful Movement

As you read chapter 4:
•
•

Try to pay close attention to the difference between stress reaction and stress
response defined by the authors.
Think about your own experience. Much like how you identified your own stress
symptoms in chapter two, identify the following:
o Your physical stress reactions: these might include elevated heart rate,
sweating, muscle pains, or other physical symptoms:
____________________________________________________________
____________________________________________________________
____________________________________________________________
o Your behavioral stress reactions: these might include those short-term or
quick fixes you might do to help with stress, such as isolating yourself or
substance use:
____________________________________________________________
____________________________________________________________
____________________________________________________________

•

Now, try to pay close attention to how the authors define stress response or how
we might respond to stress. You might notice that you already engage in helpful
strategies during times of stress? It so, what are they?
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________

•

•

Read through Practice 4.1 on pages 63-66, which is: Sitting Meditation. Choose a
sitting posture and practice sitting meditation. This practice can take up to 30
minutes, but you can start with 10 to 20 minutes and build up to 30 minutes.
Create a schedule for yourself this week. Set aside 15 to 30 minutes of time per
day for seven days to practice the body scan and sitting meditation. Alternate
between the two practices.
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o Try to stick to your schedule. If you miss a scheduled practice, it is okay!
Try to reschedule for later in the day or complete a morning and nighttime
practice the following day.
o You can use the attached worksheet to create your schedule, or you can
write it in a notebook or planner.
As you read chapter 5:
•

•

Try to pay close attention to the context of yoga and the foundations of yoga
practice. The authors discuss several areas to get you started with a yoga practice,
including your own safety.
Read through Practice 5.1 (Lying Yoga Poses) and Practice 5.2 (Standing Yoga
Poses).
o In addition to alternating between body scan and sitting meditation,
choose at least one of these two yoga sequences to work into your
schedule three times.
o You can use the attached worksheet to create your schedule, or you can
write it in a notebook or planner.
o Remember that the authors suggest practicing yoga before a body scan or
sitting meditation practice. Yoga might also be beneficial in the morning
or at night.
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Week Four
Please read the following:
•

Chapter Six: Balancing Breath

•

Chapter Seven: Stories we Tell Ourselves

As you read chapter 6:
•

Try to pay close attention to the differences between the sympathetic nervous
system and the parasympathetic nervous system. As the authors suggest on page
101, ask yourself the following question:
o How do you breathe when you are in a tense situation, scare, or getting
ready to face a physical challenge? Check all that might apply:
___ I sharply draw in a few deep breaths
___ I hold my breath
___ I start to hyperventilate (breathe faster)
___ Other: __________________________________________________

•

Read through and attempt each type of mini-breathing practice. Once you
practice each, write down which mini practice or practices you might use during
times of stress:
__________________________________________________________________
__________________________________________________________________

•

Remember you can practice a “mini” at any point during the day on an as needed
basis.

As you read chapter 7:
•
•

Think about your own life stories. Try to pay close attention to the nature of
thought and how some of our life stories can be distressing.
Read and review common Pitfalls in Thinking.
o Can you relate with any of these defined pitfalls?

•

If so, keep in mind how Mindfulness for Observing Thoughts might help you to
begin recognizing these thought patterns through the questions outlined on page
115.
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•

Read through the instructions for Practice 7.1 on pages 115-117, which is:
Challenging Your Assumptions.
o Think of a time you might have experienced a pitfall in thinking.
Complete the practice by filling in the situation, emotions, automatic
thoughts, distortions of thought, alternate response, and outcome.
o You can use the space provided to run through an example:

•

Read though Practice 7.2 on pages 118 and 119, which is: Mindful Walking
Meditation.
o As the authors suggest, create a schedule in which you alternate between
practicing Sitting Meditation and Mindful Walking Meditation, while
also including a practice of Lying Yoga Poses or Standing Yoga Poses
within the next week.
o You can use the attached worksheet to create your schedule, or you can
write if in a notebook or planner.
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Week Five
Practice this week:
•

Use your schedule created last week to continue Sitting Meditation, Mindful
Walking Meditation, and Yoga Poses throughout this week.

Please read the following:
•

Chapter Eight: Meditation with Imagery

•

Chapter Nine: A Day of Silence

As you read chapter 8:
•
•
•

Try to pay close attention to how all senses are included within imagery and how
incorporating imagery into meditation might be beneficial to you.
Read through Practice 8.1 on pages 123-125, which is: Mountain Meditation.
Incorporate the use of nature and imagery into a sitting meditation practice this
week.
o You can approach the Mountain Meditation through one of the ways the
authors suggest given your preference:
▪ Ask a friend to read the practice out loud
▪ Create a recording and listen to the practice
▪ Allow the instructions to guide you as you read through the
practice.

As you read chapter 9:
• Try to pay close attention to why a Day of Silence might be beneficial as well as
the sample provided on page 130.
• Read through Practice 9.1 on pages 131-133, which is: Loving-Kindness
Meditation.
• Start to plan your own day of silence.

•

o You can use the attached worksheet to create your own structured
schedule.
o Remember the tips and recommendations for how to plan for a day of
silence on page 135.
▪ Prepare your materials (e.g., recordings, breaks, lunch) beforehand.
Find a day during WEEK SIX that is best for you to have a day of silence.

87

88

Week Six
Practice this week:
•

•

Use your schedule created last week to continue Sitting Meditation, Mindful
Walking Meditation, and Yoga Poses throughout this week.
o You could also modify your schedule on your own or with the provided
blank worksheet.
This is also the week you should have your Day of Silence scheduled; during
which, you will use the schedule you created last week.

Please read the following:
•

Chapter Ten: Deepening and Expanding

•

Chapter Eleven: Moving into the World

As you read chapter 10:
•

Read through Practice 10.1 on pages 138-139, which is: Choiceless Awareness as
well as the example of how an individual used this practice provided on page 140.
o Incorporate this practice into your Day of Silence.

As you read chapter 11:
•

Begin to think about the possibility of seeking a support group that might aid in
continuing mindfulness practice.
o Many groups are available in-person or online virtually. Information might
be available through asking your doctor or medical provider.
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Week Seven
Practice this week:
•

As you continue Sitting Meditation, Mindful Walking Meditation, and Yoga
Poses throughout this week, also incorporate Loving-Kindness Meditation and
Choiceless Awareness practice into your routine.
o You could create this new schedule on your own or with the provided
blank worksheet.

Please read the following:
•

Chapter Twelve: Mindful Coping with Cancer-Related Symptoms and Side
Effects

As you read chapter 10:
•

Try to pay close attention to the symptoms and corresponding practices that might
be relevant to you and your experience:
o Read through Practice 12.1 on page 153, which is: Who are you?
o Read through Practice 12.2 on page 156, which is: Sleep Practice.
o Read through Practice 12.3 on page 160, which is Reducing Anticipatory
Nausea.

•

Think about how some of these practices might be incorporated into your routine.
This would be dependent on relevance to you.
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Week Eight
Practice this week:
•

Use your schedule created last week to continue Sitting Meditation, Mindful
Walking Meditation, Yoga Poses, Loving-Kindness Meditation, and Choiceless
Awareness throughout this week.
o You could also modify your schedule on your own or with the provided
blank worksheet.

Please read the following:
•

Chapter Thirteen: Knowing Your Fear and Other Difficult Emotions

•

Chapter Fourteen: What Now?

As you read chapter 13:
•

Try to pay close attention to how avoidance actually acts as a reinforcer.

•

Read through how the authors describe quieting the anxious mind and think about
how sitting with an uncomfortable emotion might benefit you in the long-term.

As you read chapter 14:
•

•

This about how you might incorporate informal mindfulness into your daily life.
As the authors suggest on page 171, choose a cue to remind yourself to practice
mindfulness every day.
Read through Practice 14.1 on page 172, which is: Living Meditation as well as
Practice 14.2 on pages 175-176, which is Healing Meditation.
o With these two practices in mind, think about how you might use
mindfulness to increase your daily awareness to live moment by moment.
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Appendix B
Email Examples
[Example of Weekly Check-In Email]:

Hi ____________,
This is the first email for the study you are now participating in, which is entitled
“Examining the Feasibility of Implementing a Mindfulness-Based Cancer Recovery
Through Guided Bibliotherapy to Reduce Psychosocial Distress in Women with Breast
Cancer.” As I mentioned yesterday, you will receive weekly emails that will include the
instructions for that week. Every two weeks, the email will include the links to surveys.
Your emails will be coming to you each: Wednesday/Saturday and you will also get a
reminder email each: Saturday/Tuesday.
Regarding your participation for this week, please refer to your Week One Module (the
PDF attached to this email). As you will see, your reading for this week includes
Chapters 1 and 2 of your self-help book. Please try to pay close attention to the “As you
read these chapters:” section in the module. This is meant to help guide you through the
reading and includes questions for you to think about and/or answer.
Please respond to this email if you have any questions. This email is monitored daily.
As a result, your questions might not be answered immediately, but they will be answered
within 24 hours. If you have any concerns that you think might be best addressed through
a phone conversation, you can respond to this email requesting a phone call from the
Principal Investigator. Along with your request for an additional phone discussion, please
provide the phone number to best contact you as well as the day and time you might be
best reached. You will receive an email indicating when you will be contacted about
your concerns.
Sincerely,
Juliana
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[Example of Weekly Reminder Email]:
Hi ____________,
This email is to serve as a friendly reminder to complete this week’s module for your
participation in the study entitled, “Examining the Feasibility of Implementing a
Mindfulness-Based Cancer Recovery Through Guided Bibliotherapy to Reduce
Psychosocial Distress in Women with Breast Cancer.”
To remind you, regarding your participation for this week, please refer to your Week
One Module (PDF attached to this email). As you will see, your reading for this week
includes Chapters 1 and 2 of your self-help book. Please try to pay close attention to the
“As you read these chapters” section in the module. This section is meant to help guide
you through the reading and includes questions for you to answer.
Please respond to this email if you have any questions. This email is monitored daily.
As a result, your questions might not be answered immediately, but they will be answered
within 24 hours. If you have any concerns that you think might be best addressed through
a phone conversation, you can respond to this email requesting a phone call from the
Principal Investigator. Along with your request for an additional phone discussion, please
provide the phone number to best contact you as well as the day and time you might be
best reached. You will receive an email indicating when you will be contacted about
your concerns.
Sincerely,
Juliana
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[Example of Weekly Check-In Email (with surveys)]:
Hi __________,
This email is to serve as a check-in for the study you are currently participating in, which
is entitled “Examining the Feasibility of Implementing a Mindfulness-Based Cancer
Recovery Through Guided Bibliotherapy to Reduce Psychosocial Distress in Women with
Breast Cancer.”
Regarding your participation for this week, please refer to your Week Two Module
(PDF attached to this email). As you will see, your reading for this week includes
Chapter 3 of your self-help book. Please try to pay close attention to the “As you read
these chapters” section in the module, which is meant to help guide you through the
reading and includes questions for you to answer. This week, the module also includes
instructions for how to create a schedule to engage in mindfulness-based practices
throughout this week.
In addition, please complete the following surveys by clicking the links below or by
pasting them into your browser’s search bar. As a reminder, your identification
number is: XX. You have the option to complete all surveys at the same time OR you
can complete each survey separately. Please complete only one of these options;
specifically, if you choose to click the link for “All surveys,” you should not click the
links for each individual survey. Please make sure surveys are completed on: XXX by
11:59pm.
• All Surveys: https://rowan.co1.qualtrics.com/jfe/form/SV_4184MOX22MZkeoZ
• Survey 1: https://rowan.co1.qualtrics.com/jfe/form/SV_6XND8W1CNLnFrcp
• Survey 2: https://rowan.co1.qualtrics.com/jfe/form/SV_cCLPOYulKomOzzv
• Survey 3: https://rowan.co1.qualtrics.com/jfe/form/SV_1H9QmqbDnojVFvD
• Survey 4: https://rowan.co1.qualtrics.com/jfe/form/SV_23rFFOXksRgO58x
Please respond to this email if you have any questions. This email is monitored daily.
As a result, your questions might not be answered immediately, but they will be answered
within the next 24 hours. If you have any concerns that you think might be best addressed
through a phone conversation, you can respond to this email requesting a phone call from
the Principal Investigator. Along with request for an additional phone discussion, please
provide the phone number to best contact you as well as the day of the week and time of
the day you are best reached. You will receive an email including the day and time we
will contact you about your concerns.
Sincerely,
Juliana
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